Global action is the only way to get ahead of Covid-19

By Mark Suzman This week, we learned that the COVID-19 vaccine developed by the University of Oxford and AstraZeneca appears to provide no measurable effect on mild or moderate disease caused by the variant of the virus first identified in South Africa, known as B.1.351. This is deeply disappointing news. People the world over are understandably frustrated